Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2015

Open Access 01-12-2015 | Research article

Pregnant womens’ concerns when invited to a randomized trial: a qualitative case control study

Authors: Katrien Oude Rengerink, Sabine Logtenberg, Lotty Hooft, Patrick M. Bossuyt, Ben Willem Mol

Published in: BMC Pregnancy and Childbirth | Issue 1/2015

Login to get access

Abstract

Background

Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug Administration nowadays allows - and even encourages - responsible inclusion of pregnant women in trials with adequate safety monitoring. Still, randomized trials in pregnant women face specific enrolment challenges. Previous studies have focused on barriers to trial participation in studies that had failed to recruit sufficient participants. Our aim was to identify barriers and motivators for participation in a range of clinical trials being conducted in the Netherlands, regardless of recruitment performance.

Methods

We performed a qualitative case control study in women who had been asked in 2010 to participate in one of eight clinical trials during pregnancy or shortly after giving birth. Both participants and non-participants of these clinical trials were invited for a face-to-face interview that addressed motives for participation and non-participation. We started the interview in an open fashion, asking the women for their main motive for participation or non-participation. When no new information emerged in this open part, we continued with a semi-structured interview, guided by a topic list. Transcripts of the interviews were analysed using a constant-comparative approach. Two researchers identified barriers and facilitators for participation, conjoined into main themes.

Results

Of 28 women invited for the interview, 21 agreed to be interviewed (12 participants and 9 non-participants). For 5 of the 12 participants, contribution to scientific research was their main motive, while 5 had participated because the intervention seemed favorable and was not available outside the trial. Key motives for non-participation (n = 9) were a negative association or a dislike of the intervention, either because it might do harm (n = 6) or for practical reasons (n = 3). Combining the open and topic list guided interviews we constructed seven main themes that influence the pregnant women’s decision to participate: external influence, research and healthcare, perception own situation, study design, intervention, information and counselling, and uncertainty.

Conclusions

Among seven main themes that influence pregnant women’s decision to participate, uncertainty about scientific research or the intervention was reported to be of considerable importance. Measures should be taken to habituate pregnant women more to scientific research, and further evaluation of opt-out consent deserves attention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA. Women in clinical trials of new drugs – a change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials. N Engl J Med. 1993;329:292–6.CrossRefPubMed Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA. Women in clinical trials of new drugs – a change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials. N Engl J Med. 1993;329:292–6.CrossRefPubMed
3.
go back to reference Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191:398–407.CrossRefPubMed Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191:398–407.CrossRefPubMed
4.
go back to reference Lyerly AD, Little MO, Faden R. The second wave: towards responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth. 2008;1:5–22.CrossRefPubMedPubMedCentral Lyerly AD, Little MO, Faden R. The second wave: towards responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth. 2008;1:5–22.CrossRefPubMedPubMedCentral
5.
go back to reference Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K. Increasing participation of women in early phase clinical trials approved by the FDA. Women’s Health Issues. 2009;19:89–93.CrossRefPubMed Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K. Increasing participation of women in early phase clinical trials approved by the FDA. Women’s Health Issues. 2009;19:89–93.CrossRefPubMed
6.
go back to reference Mohanna K, Tunna K. Withholding consent to participate in clinical trials: decisions of pregnant women. BJOG. 1999;106:892–7.CrossRef Mohanna K, Tunna K. Withholding consent to participate in clinical trials: decisions of pregnant women. BJOG. 1999;106:892–7.CrossRef
7.
go back to reference Tooher RL, Middleton PF, Crowther CA. A thematic analysis of factors influencing recruitment to maternal and perinatal trials. BMC Preg Childbirth. 2008;8:36.CrossRef Tooher RL, Middleton PF, Crowther CA. A thematic analysis of factors influencing recruitment to maternal and perinatal trials. BMC Preg Childbirth. 2008;8:36.CrossRef
8.
go back to reference Oude Rengerink K, Opmeer BC, Logtenberg SL, et al. Improving participation of patients in clinical trials – rationale and design of IMPACT. BMC Med Res Methodol. 2010;10. Oude Rengerink K, Opmeer BC, Logtenberg SL, et al. Improving participation of patients in clinical trials – rationale and design of IMPACT. BMC Med Res Methodol. 2010;10.
9.
go back to reference Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudijk MA, de Haan TR, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth. 2010;10:8.CrossRefPubMedPubMedCentral Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudijk MA, de Haan TR, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth. 2010;10:8.CrossRefPubMedPubMedCentral
10.
go back to reference Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HC, Bloemenkamp KW, et al. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (Apostel-I trial). BMC Pregnancy Childbirth. 2009;9:38.CrossRefPubMedPubMedCentral Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HC, Bloemenkamp KW, et al. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (Apostel-I trial). BMC Pregnancy Childbirth. 2009;9:38.CrossRefPubMedPubMedCentral
11.
go back to reference Roos C, Spaanderman ME, Schuit E, Bloemenkamp KW, Bolte AC, Cornette J, et al. Effect of maintenance tocolysis with nifedepine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. JAMA. 2013;309:41–7.CrossRefPubMed Roos C, Spaanderman ME, Schuit E, Bloemenkamp KW, Bolte AC, Cornette J, et al. Effect of maintenance tocolysis with nifedepine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. JAMA. 2013;309:41–7.CrossRefPubMed
12.
go back to reference Magee LA, von Dadelsze P, Chan S, Gafni A, Gruslin A, Helewa M, et al. The control of hypertension in pregnancy study pilot trial. BJOG. 2007;114:770. e13-20.CrossRefPubMed Magee LA, von Dadelsze P, Chan S, Gafni A, Gruslin A, Helewa M, et al. The control of hypertension in pregnancy study pilot trial. BJOG. 2007;114:770. e13-20.CrossRefPubMed
13.
go back to reference Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014;121:1005–14.CrossRefPubMed Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014;121:1005–14.CrossRefPubMed
14.
go back to reference Van der Ham DP, Vijgen SM, Nijhuis JG, van Beek JJ, Opmeer BC, Mulder AL, et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Med. 2012;9:e1001208.CrossRefPubMedPubMedCentral Van der Ham DP, Vijgen SM, Nijhuis JG, van Beek JJ, Opmeer BC, Mulder AL, et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Med. 2012;9:e1001208.CrossRefPubMedPubMedCentral
15.
go back to reference Langeveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks’ gestation (Hypitat II): a multicenter, open-label randomised controlled trial. BMC Preg Childbirth. 2011;11:50.CrossRef Langeveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks’ gestation (Hypitat II): a multicenter, open-label randomised controlled trial. BMC Preg Childbirth. 2011;11:50.CrossRef
16.
go back to reference Liem S, Schiut E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet. 2013;382:1341–9.CrossRefPubMed Liem S, Schiut E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet. 2013;382:1341–9.CrossRefPubMed
17.
go back to reference Lucassen PLBJ, Olde Hartman TC. Kwalitatief onderzoek. Houten: Bohn Stafleu van Loghum; 2007.CrossRef Lucassen PLBJ, Olde Hartman TC. Kwalitatief onderzoek. Houten: Bohn Stafleu van Loghum; 2007.CrossRef
18.
go back to reference Boeije H. Analyseren in kwalitatief onderzoek. Amsterdam: Boom onderwijs; 2008. Boeije H. Analyseren in kwalitatief onderzoek. Amsterdam: Boom onderwijs; 2008.
19.
go back to reference Kenyon S, Dixon-Woods M, Jackson CJ, Windridge K, Pitchford E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006;15:98–101.CrossRefPubMedPubMedCentral Kenyon S, Dixon-Woods M, Jackson CJ, Windridge K, Pitchford E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006;15:98–101.CrossRefPubMedPubMedCentral
20.
go back to reference McCann SK, Campbell MK, Enwtistle VA. Reasons for participating in randomised controlled trials: conditional altruism and consideration for self. Trials. 2010;11:31.CrossRefPubMedPubMedCentral McCann SK, Campbell MK, Enwtistle VA. Reasons for participating in randomised controlled trials: conditional altruism and consideration for self. Trials. 2010;11:31.CrossRefPubMedPubMedCentral
21.
go back to reference Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52:1143–56.CrossRefPubMed Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52:1143–56.CrossRefPubMed
22.
go back to reference Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, et al. Risks, values and decision making surrounding pregnancy. Obstet Gynecol. 2007;109:979–84.CrossRefPubMed Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, et al. Risks, values and decision making surrounding pregnancy. Obstet Gynecol. 2007;109:979–84.CrossRefPubMed
23.
go back to reference Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholz DA, Edwards SJ, et al. Lay public’s understanding of equipoise and randomization in randomized controlled trials. Health Technol Assess. 2005;8:1–192. Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholz DA, Edwards SJ, et al. Lay public’s understanding of equipoise and randomization in randomized controlled trials. Health Technol Assess. 2005;8:1–192.
25.
go back to reference Junghans C, Feder G, Hemingway H, Timmis A, Jones M. Recruiting patients to medical research: double blind randomized trial of ‘opt-in’ versus ‘opt-out’ strategies. BMJ. 2005;331:940.CrossRefPubMedPubMedCentral Junghans C, Feder G, Hemingway H, Timmis A, Jones M. Recruiting patients to medical research: double blind randomized trial of ‘opt-in’ versus ‘opt-out’ strategies. BMJ. 2005;331:940.CrossRefPubMedPubMedCentral
26.
go back to reference Crombie IK, McMurdo ME, Irvine L, Williams B. Overcoming barriers to recruitment in health research. Concerns of potential participants need to be dealt with. BMJ. 2006;333:398.CrossRefPubMedPubMedCentral Crombie IK, McMurdo ME, Irvine L, Williams B. Overcoming barriers to recruitment in health research. Concerns of potential participants need to be dealt with. BMJ. 2006;333:398.CrossRefPubMedPubMedCentral
27.
go back to reference Mackenzie IS, Wei L, Rutherford D, Findlay EA, Saywood W, Campbell MK, et al. Promoting public awareness of randomised clinical trials using the media: the ‘Get randomised’ campaign. Br J Clin Pharmacol. 2010;69:128–35.CrossRefPubMedPubMedCentral Mackenzie IS, Wei L, Rutherford D, Findlay EA, Saywood W, Campbell MK, et al. Promoting public awareness of randomised clinical trials using the media: the ‘Get randomised’ campaign. Br J Clin Pharmacol. 2010;69:128–35.CrossRefPubMedPubMedCentral
Metadata
Title
Pregnant womens’ concerns when invited to a randomized trial: a qualitative case control study
Authors
Katrien Oude Rengerink
Sabine Logtenberg
Lotty Hooft
Patrick M. Bossuyt
Ben Willem Mol
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2015
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-015-0641-x

Other articles of this Issue 1/2015

BMC Pregnancy and Childbirth 1/2015 Go to the issue